Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
Abstract Alzheimer’s disease (AD) is characterized by amyloid (Aβ) protein aggregation and neurofibrillary tangles accumulation, accompanied by neuroinflammation. With all the therapeutic attempts targeting these biomarkers having been unsuccessful, the understanding of early mechanisms involved in...
Main Authors: | Yesica Gloria, Kelly Ceyzériat, Stergios Tsartsalis, Philippe Millet, Benjamin B. Tournier |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-99025-1 |
Similar Items
-
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
by: Darlene A. Mitrano, et al.
Published: (2021-06-01) -
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
by: Benjamin B. Tournier, et al.
Published: (2020-08-01) -
Treatment of Alzheimer's disease with anti-homocysteic acid antibody in 3xTg-AD male mice.
by: Tohru Hasegawa, et al.
Published: (2010-01-01) -
Treatment of late-stage Alzheimer's disease with folate derivatives in the 3xTg-AD mice model
by: Hung-Cheng Hsu, et al.
Published: (2013) -
DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice.
by: Dany Arsenault, et al.
Published: (2011-02-01)